Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $66
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an 'Outperform' rating on LeMaitre Vascular (NASDAQ:LMAT) and raised the price target from $62 to $66.
August 04, 2023 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular's price target has been raised from $62 to $66 by Barrington Research, which maintains an 'Outperform' rating on the stock.
The raised price target and maintained 'Outperform' rating by Barrington Research indicates a positive outlook for LeMaitre Vascular. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100